Cargando…
“Peritoneal failure”: A new concept to explain negative results of randomized trials evaluating intraperitoneal therapies
Autores principales: | Pocard, Marc, Reymond, Marc A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292232/ https://www.ncbi.nlm.nih.gov/pubmed/32566729 http://dx.doi.org/10.1515/pp-2020-0117 |
Ejemplares similares
-
Intraperitoneal aerosolization of albumin-stabilized paclitaxel nanoparticles (Abraxane™) for peritoneal carcinomatosis – a phase I first-in-human study
por: Van De Sande, Leen, et al.
Publicado: (2018) -
PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study
por: Eveno, Clarisse, et al.
Publicado: (2018) -
Hyperthermic intraperitoneal chemotherapy with cisplatin and mitomycin C for colorectal cancer peritoneal metastases: A systematic review of the literature
por: Pinto, Amandine, et al.
Publicado: (2019) -
Active Negative Pressure Peritoneal Therapy After Abbreviated Laparotomy: The Intraperitoneal Vacuum Randomized Controlled Trial
por: Kirkpatrick, Andrew W., et al.
Publicado: (2015) -
Photodynamic therapy and photothermal therapy for the treatment of peritoneal metastasis: a systematic review
por: Pinto, Amandine, et al.
Publicado: (2018)